|
Status |
Public on Feb 27, 2014 |
Title |
LCC9 shLRH-1 rep1 |
Sample type |
RNA |
|
|
Source name |
LCC9, shRNA LRH-1
|
Organism |
Homo sapiens |
Characteristics |
tissue: breast cancer cell line: LCC9 endocrine sensitivity: endocrine resistant (Tamoxifen and Fulvestrant)
|
Treatment protocol |
Cells were transduced with shLRH-1 or shCTL lentiviruses for 4 days before mRNA extraction.
|
Growth protocol |
LCC9 are maintained in DMEM without phenol red containing 5% charcoal-dextran treated FBS, glutamine and antibiotics.
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was isolated using the GenElute mammalian total RNA miniprep kit (Sigma).
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared according to standard Illumina protocol at McGill University & Genome Quebec Innovation Centre
|
|
|
Hybridization protocol |
Standard Illumina hybridization protocol
|
Scan protocol |
Standard Illumina scanning protocol
|
Data processing |
Log2 transformation and quantile normalization of the data were performed with FlexArray 1.6.3 software
|
|
|
Submission date |
Feb 11, 2014 |
Last update date |
Feb 27, 2014 |
Contact name |
Nicolas Gévry |
E-mail(s) |
nicolas.gevry@usherbrooke.ca
|
Organization name |
Université de Sherbrooke
|
Street address |
2500 boulevard de l'université
|
City |
Sherbrooke |
State/province |
Québec |
ZIP/Postal code |
J1K 2R1 |
Country |
Canada |
|
|
Platform ID |
GPL10558 |
Series (2) |
GSE54891 |
LRH-1 governs vital transcriptional programs in endocrine sensitive and resistant breast cancer cells: Expression profiling |
GSE54892 |
LRH-1 governs vital transcriptional programs in endocrine sensitive and resistant breast cancer cells |
|